MedTrace Logo

Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.

NCT01486407 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2026-01-08

Study results available
· View outcomes & findings →

Summary

This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.

Conditions

  • Airway Control

Sponsors & Collaborators

  • Vidacare Corporation

    lead INDUSTRY

Principal Investigators

  • Stephen W Borron, MD · Texas Tech University Health Science Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01486407 on ClinicalTrials.gov